-
Post-PD-1 era double anti-hot spot bursts 50 billion market is about to open
Time of Update: 2022-06-11
On January 5, 2022, Kangfang Bio announced that its self-developed world's first innovative new tumor immunotherapy drug AK104 (PD-1/CTLA-4 double antibody, kadonilimumab) combined with AK112 (PD-1/VEGF double antibody) Anti) Phase Ib/II clinical trial application was approved by CDE, with or without chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC) .
-
Accelerated approval of oncology drug withdrawals in 'acceleration'
Time of Update: 2022-06-11
Among the 167 indications for accelerated approval of oncology drugs, 66 are undergoing confirmatory trials, 83 have been finalized and 83 have been approved by the FDA, and 18 have been withdrawn .
-
Gilead's oncology business could account for a third of total revenue by 2030
Time of Update: 2022-06-11
According to the company's financial report, Gilead's 2021 oncology revenue will mainly come from six products, most of which will come from breast cancer drug Trodelvy ($380 million), cell therapy Yescarta ($695 million) and Tecartus ($176 million) .
-
Several main features of the traditional Chinese medicine automatic paste concentrator
Time of Update: 2022-06-11
The traditional Chinese medicine full-automatic paste concentrator is composed of a heating part, a rapid evaporation system and an intelligent control system.
4. Using high-performance heat-conducting oil to conduct heat, high power, high thermal efficiency, uniform heating, rapid heating, saving time and electricity .
-
What are the advantages of vacuum nitrogen filling packaging machine
Time of Update: 2022-06-11
75kw of power consumption of the vacuum pump, the packaging speed is more than twice that of the general cavity packaging machine, and the energy consumption is only 40% of the same type of packaging machine .
-
The list of next-generation leaders in the field of biomedicine is released, and 21 young talents are on the list
Time of Update: 2022-06-11
It completed a $140 million Series A financing last year and entered into a strategic partnership with CRISPR Therapeutics to jointly develop in vivo gene editing therapies delivered by engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS) and epilepsy Riedreich's ataxia .
-
How to clean the oral liquid filling machine
Time of Update: 2022-06-11
Use the drying process to maintain the operating equipment to clean the filling parts inside the liquid filling machine, such as the gas-water separator, and mineral oil is required when depositing glass on the filter.
-
Advantages and daily maintenance of disinfectant filling production line
Time of Update: 2022-06-11
The disinfectant filling production line developed by Shanghai Shenggang is a fully functional automatic equipment .
During the production process of the disinfectant filling production line, the biological stability and sterilization of the bottled liquid should be guaranteed .
-
What are the differences between automatic paste filling machine and semi-automatic paste filling machine
Time of Update: 2022-06-11
2. Scope problem: Although the automatic paste filling machine is relatively expensive and saves manpower, it also has certain limitations.
The automatic paste filling machine and the semi-automatic paste filling machine have their own advantages and disadvantages.
-
Japan's first!
Time of Update: 2022-06-11
On April 19, Takeda announced that the new crown vaccine Nuvaxovid (NVX-CoV2373) has been approved for marketing in Japan for primary and booster immunizations of people 18 years of age and older .
-
Are Pfizer Paxlovid and Merck Molnupiravir cost-effective?
Time of Update: 2022-06-11
3 Hospital shared clinical cases of antiviral treatment for patients with COVID-19 (Omicron), including the use of Pfizer's oral novel coronavirus small molecule drug Paxlovid (Nematavir/ritonavir).
-
The market soared 95.31%!
Time of Update: 2022-06-11
com, in 2021, the sales volume of Chinese online pharmacy terminal diabetes chemical drugs will be close to 1 billion yuan, a year-on-year increase of 95.
-
11 product centralized procurement won the bid for one year to achieve blood-returning letter Litai what to look forward to in the future
Time of Update: 2022-06-11
On the evening of April 18, Xinlitai released the first-quarter results announcement, saying that the revenue in the first quarter of 2022 was about 935 million yuan, a year-on-year increase of 22.
Deducted non-net profit of 182 million yuan, a year-on-year increase of 22.
-
Wide application of automatic liquid filling machine in the market
Time of Update: 2022-06-11
1. Pharmaceutical industry filling machine medicines are available in the form of powder, cream or lotion, liquid or syrup and tablet .
Products used in the cosmetic industry are usually viscous, so machines used in the cosmetic industry are specially designed to handle the filling of viscous liquids and creams .
-
What should be paid attention to when the stainless steel sanitary centrifugal pump is shut down?
Time of Update: 2022-06-10
The volute is the stationary part that converts kinetic energy into pressure .
5. When the low-temperature sanitary centrifugal pump stops running, if there are no special requirements, the pump body should be filled with liquid; 6.
-
What will lead the next revolution in cancer care in the next decade?
Time of Update: 2022-06-09
Zhang Youxiang, CEO of WuXi Biotech, said: "I believe that in the near future , industrial innovation and breakthroughs will bring great progress in the manufacturing process of cell and gene therapy, and the manufacturing of new-generation therapies will become more and more Standardization, industrialization, large-scale, stable process and controllable cost, thus providing treatment options for many diseases including cancer and rare diseases .
-
Top biotechnology financing list released!
Time of Update: 2022-06-09
Judging from the 2021 list of the top 10 private financing of biotechnology companies screened by Fierce Biotech, cell and gene therapy (CGT) is a hot spot for financing, and new crown vaccines and therapeutic products, and AI pharmaceuticals are also favored by capital .
-
Die installation method of rotary tablet press
Time of Update: 2022-06-09
3. Install the middle die of the rotary tablet press, loosen the fixing screws of the middle die, place the middle die flat in the hole of the plywood of the middle die, and at the same time make the lower punch enter the hole of the middle die, and press it to the bottom , and then tighten it .
-
Problems that must be paid attention to when choosing a couplant filling machine
Time of Update: 2022-06-09
The answer is not necessarily; Shanghai Shenggang Machinery filling machine R&D manufacturer warns everyone: to buy a machine, you need to shop around and abandon the traditional concept.
Therefore, the main thing to buy a couplant filling machine is to look at the machine itself, not the manufacturer .
-
Almost unanimously passed!
Time of Update: 2022-06-09
m. Beijing time on April 22, the FDA ended the 4-hour Oncology Drug Advisory Committee (ODAC) for PI3K drugs with 16 votes in favor, 1 abstention to approve future indications of PI3K inhibitors in hematological malignancies, requiring randomized controlled data support for active drugs .
